Faculty
Lynn E. DeLisi, MD
Laboratory Director; Director of RISE Early Psychosis Treatment Team and Vice-Chair for Faculty Affairs and Development, Department of Psychiatry, Cambridge Health Alliance; Professor of Psychiatry, Harvard Medical School. Her research is focused on biological markers of psychosis and their prediction of treatment response. She has future research aimed to understand the underlying basis for an association of cannabis use with schizophrenia and interventions to prevent its continued abuse by patients with this diagnosis.
Norah Mulvaney-Day, PhD
Raquelle Mesholam-Gately, PhD; Co-Director and Program Leader of RISE, Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School.
Andrew Hyatt, MD
Adult psychiatrist, Medical Director of the Cambridge Health Alliance Health Integration Program for psychotic disorders (HIP), Instructor in Psychiatry, Harvard Medical School. He is an NIH K23 Career Development Awardee through the National Institute of Drug Abuse (NIDA) to study the effect of adult use cannabis legalization on individuals with schizophrenia and related conditions, and has found some of the first evidence that legalization may disproportionately harm vulnerable individuals with psychotic disorders.
Yveton Isnor, PsyD
Psychologist in the RISE program, Instructor of Psychology in the Department of Psychiatry, Harvard Medical School. His interest is focused on the prediction and prevention of violence and aggressive behavior in people with schizophrenia.
Clifton Chow, PhD
Statistician and Instructor in Psychiatry, Harvard Medical School
Staff
Esi Coro, MS, Research Coordinator
Trainees
Gil Grunfeld, MSc, MA, is a PhD student in Clinical Psychology at Boston University's Department of Psychological & Brain Sciences. She joined the Psychosis Research Lab at Cambridge Health Alliance in 2023 and began work as a psychotherapy trainee in the ISE clinic in Fall 2025.
Her research interests include the phenomenology of early course psychosis, self-other connection, and loneliness. In 2025, Gil was awarded the NIMH F31 training grant to conduct research on loneliness in first-episode psychosis recovery with the Psychosis Research Lab.
Jeffery Lam, MD: